- $1.53bn
- $1.94bn
- $844.01m
- 81
- 38
- 20
- 43
Annual income statement for Rapid7, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 411 | 535 | 685 | 778 | 844 |
Cost of Revenue | |||||
Gross Profit | 290 | 366 | 471 | 546 | 593 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 486 | 658 | 797 | 916 | 809 |
Operating Profit | -74.1 | -123 | -112 | -138 | 35 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -96.9 | -136 | -122 | -153 | 41.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -98.8 | -146 | -125 | -153 | 25.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -98.8 | -146 | -125 | -153 | 25.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -98.8 | -146 | -125 | -153 | 25.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.9 | -2.42 | -2.13 | -1.37 | 0.409 |